Mersana Therapeutics Inc (0M40)

Currency in EUR
6.54
-0.41(-5.91%)
Closed·
0M40 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
6.427.00
52 wk Range
5.8265.07
Key Statistics
Bid/Ask
0.26 / 0.27
Prev. Close
6.56
Open
6.95
Day's Range
6.42-7
52 wk Range
5.82-65.07
Volume
523
Average Volume (3m)
1.08K
1-Year Change
-86.58%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
0M40 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.

Mersana Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy

Mersana Therapeutics Inc Company Profile

Mersana Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops antibody-drug conjugates (ADC) for cancer patients with unmet needs. The company develops Emi-Le (XMT-1660), a B7-H4-targeting Dolasynthen ADC candidate, which is in Phase 1 clinical trial; and XMT-2056, an Immunosynthen ADC targeting a novel human epidermal growth factor receptor 2 that is in Phase 1 clinical trial. Its preclinical products portfolio includes XMT-2068 and XMT-2175. It has strategic research and development collaborations with Janssen Biotech, Inc., Ares Trading S.A., Merck KGaA, and Asana Biosciences, LLC for the development of ADC product candidates. The company was formerly known as Nanopharma Corp. and changed its name to Mersana Therapeutics, Inc. in November 2005. Mersana Therapeutics, Inc. was incorporated in 2001 and is headquartered in Cambridge, Massachusetts.

Compare 0M40 to Peers and Sector

Metrics to compare
0M40
Peers
Sector
Relationship
P/E Ratio
0.0x0.0x0.0x
PEG Ratio
0.000.000.00
Price/Book
0.0x0.0x0.0x
Price / LTM Sales
0.0x0.0x0.0x
Upside (Analyst Target)
0.0%0.0%0.0%
Fair Value Upside
Unlock0.0%0.0%Unlock

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

0M40 Income Statement

People Also Watch

25.79
CNC
+1.02%
54.290
ASTS
+2.26%
14.00
OSCR
+1.16%
3.415
DOMI
-1.44%
50.510
SMR
+3.14%

FAQ

What Stock Exchange Does Mersana Therapeutics Inc Trade On?

Mersana Therapeutics Inc is listed and trades on the Frankfurt Stock Exchange stock exchange.

What Is the Stock Symbol for Mersana Therapeutics Inc?

The stock symbol for Mersana Therapeutics Inc is "0M40."

What Is the Mersana Therapeutics Inc Market Cap?

As of today, Mersana Therapeutics Inc market cap is 29.46M.

What Is Mersana Therapeutics Inc's Earnings Per Share (TTM)?

The Mersana Therapeutics Inc EPS (TTM) is 0.00.

From a Technical Analysis Perspective, Is 0M40 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Mersana Therapeutics Inc Stock Split?

Mersana Therapeutics Inc has split 0 times.

What is the current trading status of Mersana Therapeutics Inc (0M40)?

As of 31 Jul 2025, Mersana Therapeutics Inc (0M40) is trading at a price of 6.54, with a previous close of 6.56. The stock has fluctuated within a day range of 6.42 to 7.00, while its 52-week range spans from 5.82 to 65.07.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.